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   We experienced a case of malignant Mullerian mixed 
tumor of the uterus of a 58-year-old female. We performed an 
immunohistochemical study in order to analyze the expres-
sion of various antigens in different elements of this tumor. 
Keratin, carcinoembryonic antigen (CEA), and epithelial 
membrane antigen (EMA) showed strong positive results in 
epithelial component, while EMA also showed positive 
results in some areas of sarcomatous elements. On the other 
hand, vimentin and S-100 gave strong positive result in 
non-epithelial component, but also was positive to some 
extent in epithelial component in this tumor. Immuno-
histochemical method was useful to differentiate the different 
components of this tumor. However, EMA, Vimentin and 
S-100 showed some unusual results. This discrepancy may 
indicate a change in the nature of tumor cells due to 
`microenvironmental' factors such as hormones and vita -
mins. Therefore, careful evaluation is necessary to interpret 
the immunohistochemical results in surgical pathology. 
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Introduction 
 Malignant Mullerian mixed tumor of the female genital 
tract is a rare neoplasm of uncertain histogenesis. The 
origin of this tumor is said to be Mullerian, and the terms 
`malignant Mullerian mixed tumor' or `malignant 
mesodermal mixed tumor' (MMMT) have been applied to 
uterine neoplasms which are composed of mixture of 
malignant epithelial and mesenchymal elements'). About 
50% of the uterine sarcomas accounts for MMMT 2). The 
patients are usually elderly postmenopausal and a large 
proportion of the patients had a prior history of having 
radiotherapy"'). It arises most frequently in the uterine 
corpus, but also occurs rarely at other sites such as the 
ovary, vagina and pelvic wall'). Routine light microscopy 
only is sometimes difficult to recognize the different 
components of MMMT. In undifferentiated cases immuno-
staining is a helpful method to indentify both an epithelial 
and a mesenchymal component. Here we report a case of 
malignant Mu llerian mixed tumor with immunohisto-
chemical study.
Case report 
 A 58-year-old female came to our university hospital on 
December 9, 1992 with a complaint of feeling a mass in the 
abdomen for two months. She had a previous history of 
vaginal carcinoma of grade III b seven years ago, that was 
totally regressed after complete radiation therapy. She 
had neither pain nor history of genital bleeding. And she 
had no other systemic diseases except mild diabetes. 
 On examination an elastic hard movable mass was found 
in the lower abdomen. Per vaginal examination revealed 
smooth vaginal wall and a closed cervix. The mass was 
confined to the body of the uterus. Ultrasonography 
showed a 8x6 cm-sized partially solid and cystic mass in 
the uterus. Computed Tomography showed high density in 
solid and low density in cystic area, respectively. By 
Magnetic Resonance Image it was confirmed that the mass 
is intrauterine and no involvement of the adnexae was 
found. The mass became reduced after drainage of 
brownish fluid by external os puncture. By hysteroscopy a 
soft and smooth surfaced yellowish tumor mass was 
observed in the uterine cavity. But no papillary lesions and 
atypical vessels were seen. Biopsy suggested adeno-
carcinoma, but frozen section of the tumor gave the 
impression of malignant Mullerian mixed tumor. 
 Total abdominal hysterectomy with bilateral salpingo-
oophrectomy was done on January 28, 1993. The lymph 
nodes could not be removed due to extensive adhesion to 
the pelvic wall probably due to the effect of previous 
radiation therapy. The patient was discharged from the 
hospital after full recovery and was advised to take a total 
6 course of chemotherapy including cisplatin 120mg/ n in 
every 4 week period. The patient completed the course and 
no recurrence has been noticed yet. 
 Laboratory findings: Her laboratory investigations 
were insignificant. CA-125 was 240 during admission, 100 
pre-operatively, 24 post-operatively and 15 in first follow 
up. 
 Microscopic findings: Routine light microscopic exami-
nation disclosed proliferation of atypical cells and necrotic 
tissue. The tumor was composed of both epithelial and 
mesenchymal components. The epithelial component was
Fig. 1. MMMT showing areas of adenocarcinoma (H.E.x 
150).
Fig. 4. Strong positive reaction for keratin was demones-
trated in adenocarcinoma (LSAB x 150).
Fig. 2. Undifferentiated sarcoma cells (H.E.x 150). Fig. 5. EMA was also strongly positive in adenocarcinoma 
(LSAB x 150).
Table 1 Results of immunohistochemistry
       Epithelial component Mesenchymal component 
           Adenocarcinoma CHS UDS
                           - -Keratin +++ 
CEA +++ - -
EMA + + + + + 
Vimentin ++ ++ +++ 
Desmin - - -
S-100 + +++ ++ 
SMA - - -
+ + + : Strong positive, + + : Positive, + : Weak positive, 
-: Negative
, CHS: Chondrosarcoma, UDS: Undifferentiated 
sarcoma cells.
Fig. 3. Chondrosarcoma with giant cells and bizarre nuclei 
(H.E.x 300).
adenocarcinoma of endometrial type (Fig. 1). The 
mesenchymal component comprised of both homologous 
and heterologous elements. The homologous component 
consisted of undifferentiated spindle-shaped sarcoma cells 
having irregular nuclei (Fig. 2). The heterologous element 
comprised of chondrosarcoma with giant cells and bizarre 
nuclei (Fig. 3). Invasion of malignant cells was noted upto 
deeper muscle layer, but the adnexae were free from the
tumor cells. 
 Immunohistochemical study: Immunoperoxidase stain-
ing was performed by labeled streptavidin-biotion (LSAB) 
method'). Primary antibodies used were keratin, epithelial 
membrane antigen (EMA), carcinoembryonic antigen 
(CEA), desmin, vimentin, smooth muscle actin (SMA) 
and S-100 protein. Positive results were obtained for 
keratin, EMA, CEA, vimentin, S-100 and no results were 
found for desmin and SMA (Table 1). Keratin (Fig.4), 
EMA (Fig. 5) and CEA showed strong reaction in
Fig. 6. Immunostaining for vimentin. Undifferentiated 
sarcoma cells revealed intense reaction and weak positive 
reaction was noted in adenocarcinoma (LSAB x 150).
Fig. 8. Strong positive reaction of S-100 protein was demon-
strated in chondrosarcoma (LSAB x 150).
Fig. 7. Immunostaining for S-100 showed weak positive 
reaction in adenocarcinoma (LSAB x 150).
Fig. 9. Chondrosarcoma cells showed weak positive reaction 
for EMA (LSAB x 300).
adenocarcinoma. Adenocarcinoma also presented positive 
vimentin (Fig. 6) and S-100 (Fig. 7). On the other hand, 
undifferentiated sarcoma cells and chondrosarcoma 
elements were strongly positive for vimentin (Fig.6) and 
S-100 (Fig. 8), respectively. Undifferentiated sarcoma cells 
were scatteredly positive for EMA. EMA also showed 
weak positive result in some area of chondrosarcoma cells 
(Fig. 9). 
Discussion 
 The most interesting feature of MMMT is the presence 
of both neoplastic epithelial and mesenchymal compo-
nents. The carcinoma in most cases is an adenocarcinoma 
(90%) and rarely others. The sarcomatous components 
may be homologous or heterologous. Homologous sarcoma 
typically has the appearance of a spindle cell sarcoma, 
leiomyosarcoma, fibrosarcoma, malignant fibrous his-
tiocytoma, undifferentiated sarcoma, or any combination 
thereof. The heterologous elements may contain one or 
more elements normally not present in the uterus. They are
as follows: rhabdomyoblasts, foci of cartilage or 
chondrosarcoma, osteoid, bone or osteosarcoma and 
liposarcoma', '). In our reported case the epithelial compo-
nent was composed of adenocarcinoma. Mesenchymal 
portion of the tumor showed both homologous and 
heterologous elements. Undifferentiated sarcoma cells 
were identified as homologous element. Foci of 
chondrosarcoma with giant cells and bizarre nuclei was the 
heterologous element of the tumor. 
 However, as to the histogenesis of MMMT developing in 
the uterine body, it is considered that the tumor arises 
from the endometrium, which is derived from the 
Mullerian system embryologically'). In addition, the least 
differentiated cells in the endometrium are regarded as the 
immediate precursors of uterine MMMT. 
 Epithelial and mesenchymal components can be easily 
separated by immunostaining. Various studies previously 
showed that epithelial components are positive for kera-
tin, EMA, CEA. On the other hand, mesenchymal compo-
nents are usually positive for desmin and vimentin 
Our study also reflected the conventional result. 
Variations of these results are also observed in different
studies 10, 18)In our case, adenocarcinoma cells were not only 
positive for epithelial markers, but also show weaker 
reaction for vimentin and S-100. The mesenchymal compo-
nents, on the other hand, also showed weak positive result 
for EMA in some area. Desmin and SMA in our case 
showed negative results in both areas. 
 Coexpression of keratin and vimentin in sarcoma and 
carcinoma such as synovial sarcoma, epitheloid sarcoma, 
ovarian carcinoma, adenocarcinoma of lung and renal cell 
carcinoma has been reported previously 14, 15,16) S-100 protein 
was also previously demonstrated in various non-nervous 
tissues and tumors 17). Like the study of Chung et al. 16) we 
also identified EMA in some areas of sarcomatous ele-
ments. S-100 was strongly positive in areas of chondro-
sarcoma and also showed positive reaction in adeno-
carcinoma and undifferentiated sarcoma cells. The 
immunohistochemical result of the present case was a 
little bit complex. 
 However, specific differentiation was much easier in 
comparison with routine histopathological examination. 
The expression of intermediate filaments and other mo-
lecular markers by tumor cells are sometimes different in 
comparison with their normal counterpart. Some papers 
stressed about the modifying role of 'microenvironmental' 
substances such as hormones, vitamins and others in the 
expression of these cell markers"). Eventually such factors 
may influence regulation of genes of these intermediate 
filaments and those of other molecular markers. It can be 
regarded as an explanation of positivity for vimentin and 
S-100 in carcinoma cells, and for EMA in chondrosarcoma 
and undifferentiated sarcoma cells. However the complex 
histogenesis of this tumor needs more elucidation.
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